BENZODIAZEPINE RECEPTOR QUANTIFICATION IN-VIVO IN HUMANS USING [C-11] FLUMAZENIL AND PET - APPLICATION OF THE STEADY-STATE PRINCIPLE

被引:173
作者
LASSEN, NA
BARTENSTEIN, PA
LAMMERTSMA, AA
PREVETT, MC
TURTON, DR
LUTHRA, SK
OSMAN, S
BLOOMFIELD, PM
JONES, T
PATSALOS, PN
OCONNELL, MT
DUNCAN, JS
ANDERSEN, JV
机构
[1] NOVO NORDISK AS, DEPT DRUG METAB, DIV CNS, MALOV, DENMARK
[2] HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND
[3] NATL HOSP, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND
关键词
BENZODIAZEPINE RECEPTORS (IN VIVO; FLUMAZENIL; POSITRON EMISSION TOMOGRAPHY; RO; 15-1788;
D O I
10.1038/jcbfm.1995.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carbon-11-labeled flumazenil combined with positron emission tomography (PET) was used to measure the concentration (B-max) of the benzodiazepine (Bz) receptor in the brain and its equilibrium dissociation constant (K-D) for flumazenil in five normal subjects. The steady-state approach was used injecting the tracer as a bolus of high specific activity. In each subject two studies were carried out. The first study was performed at essentially zero receptor occupancy, the tracer alone study. The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged constant infusion of nonlabeled (''cold'') flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period. In this second study the free concentration of unmetabolized flumazenil in plasma water was measured in multiple blood samples. The observed tissue and plasma tracer curves, calibrated in the same units of radioactivity per millimeter, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding number of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments. The noncompartmental and the compartmental analyses gave essentially the same values for the distribution volume of the tracer, the parameter used for quantitation of the Bz receptor. As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred. The five subjects had a mean K-D value of 12 nM/L of water and B-max values of the grey matter ranging from 39 +/- 11 in thalamus to 120 +/- 14 nM/L of brain in occipital cortex. Most previous studies have been based on the pseudoequilibrium approach using the brain stem as a receptor-free reference region. This yields practically the same K-D but lower B-max values than the steady-state approach presented here.
引用
收藏
页码:152 / 165
页数:14
相关论文
共 39 条
  • [31] Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A
    Lohith, Talakad G.
    Zoghbi, Sami S.
    Morse, Cheryl L.
    Araneta, Maria F.
    Barth, Vanessa N.
    Goebl, Nancy A.
    Tauscher, Johannes T.
    Pike, Victor W.
    Innis, Robert B.
    Fujita, Masahiro
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (03) : 385 - 392
  • [32] Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635
    Parsey, RV
    Oquendo, MA
    Simpson, NR
    Ogden, RT
    Van Heertum, R
    Arango, V
    Mann, JJ
    BRAIN RESEARCH, 2002, 954 (02) : 173 - 182
  • [33] Preclinical in vitro and in vivo evaluation of [11C]ORM-13070 as PET ligand for alpha-2C adrenergic receptor occupancy using PET imaging in non-human primates
    Piel, Isabel
    Constantinescu, Cristian C.
    Bethencourt, David de la Puente
    Bonsall, David R.
    Rabiner, Eugenii A.
    Zasadny, Kenneth R.
    Amenta, Amy Llopis
    Wells, Lisa A.
    Poethko, Thorsten
    Prange, Wolfgang
    Delbeck, Martina
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2024, : 677 - 689
  • [34] Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635
    Hirvonen, Jussi
    Karlsson, Hasse
    Kajander, Jaana
    Lepola, Antti
    Markkula, Juha
    Rasi-Hakala, Helena
    Nagren, Kjell
    Salminen, Jouko K.
    Hietala, Jarmo
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (04) : 465 - 476
  • [35] Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
    Slifstein, Mark
    Suckow, Raymond F.
    Javitch, Jonathan A.
    Cooper, Thomas
    Lieberman, Jeffrey
    Abi-Dargham, Anissa
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (01) : 293 - 304
  • [36] Increased Adenosine A1 Receptor Levels in Hemianopia Patients After Cerebral Injury An Application of PET Using 11C-8-Dicyclopropylmethyl-1-Methyl-3-Propylxanthine
    Suzuki, Yukihisa
    Nariai, Tadashi
    Kiyosawa, Motohiro
    Mochizuki, Manabu
    Kimura, Yuichi
    Oda, Keiichi
    Ishii, Kenji
    Ishiwata, Kiich
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (12) : 1146 - 1151
  • [37] Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
    Anne Roivainen
    Kjell Någren
    Jussi Hirvonen
    Vesa Oikonen
    Pauliina Virsu
    Tuula Tolvanen
    Juha O. Rinne
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [38] Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
    Roivainen, Anne
    Nayengren, Kjell
    Hirvonen, Jussi
    Oikonen, Vesa
    Virsu, Pauliina
    Tolvanen, Tuula
    Rinne, Juha O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (04) : 671 - 682
  • [39] PET imaging of M4 muscarinic acetylcholine receptors in rhesus macaques using [11C]MK-6884: Quantification with kinetic modeling and receptor occupancy by CVL-231 (emraclidine), a novel positive allosteric modulator
    Belov, Vasily
    Guehl, Nicolas J.
    Duvvuri, Sridhar
    Iredale, Philip
    Moon, Sung-Hyun
    Dhaynaut, Maeva
    Chakilam, Srinivas
    MacDonagh, Alexander C.
    Rice, Peter A.
    Yokell, Daniel L.
    Renger, John J.
    El Fakhri, Georges
    Normandin, Marc D.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2024, 44 (08) : 1329 - 1342